Literature DB >> 6619963

Optimization of the DTPA mixed-anhydride reaction with antibodies at low concentration.

C H Paik, P R Murphy, W C Eckelman, W A Volkert, R C Reba.   

Abstract

Diethylenetriaminepentaacetic acid (DTPA) was conjugated with antibody to human serum albumin (Ab) at low concentration (300 micrograms/ml, 2.0 microM) via the DTPA carboxycarbonyl mixed-anhydride method. To study parameters determining the balance between the degree of conjugation and the antibody-binding activity of Ab, a known concentration of the anhydride prepared at isobutylchloroformate (IBC)-to-DTPA ratios of 1, 2.1, or 4.2 was reacted with Ab. The percentage yields of the anhydride were determined by spectrophotometric and gravimetric titration. By the former method the percentage yields, based on DTPA concentration, were 18, 24, and 220, respectively, when the IBC-to-DTPA ratios were 1, 2.1, and 4.2. The corresponding percentage yields were 17, 39, and 262 when determined by the latter method. When the anhydride was prepared at an IBC-to-DTPA ratio of 2.1, an optimum conjugation giving three indium atoms per Ab was obtained, with 64% retention of antibody-binding activity. For an IBC-to-DTPA ratio of 1, the antibody retained almost 100% binding activity but the number of indium atoms incorporated (0.2) was too small. For an IBC-to-DTPA ratio of 4.2, up to 22 indium atoms were incorporated but antibody-binding activity was completely destroyed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619963

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  Effect of isoelectric point on biodistribution and inflammation: imaging with indium-111-labelled IgG.

Authors:  C I ten Kate; A J Fischman; R H Rubin; A J Fucello; D Riexinger; R A Wilkinson; L Du; B A Khaw; H W Strauss
Journal:  Eur J Nucl Med       Date:  1990

Review 2.  Approaches to radiolabeling of antibodies for diagnosis and therapy of cancer.

Authors:  A R Fritzberg; R W Berninger; S W Hadley; D W Wester
Journal:  Pharm Res       Date:  1988-06       Impact factor: 4.200

3.  Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.

Authors:  In Soo Shin; Sang-Myung Lee; Hyung Sub Kim; Zhengsheng Yao; Celeste Regino; Noriko Sato; Kenneth T Cheng; Raffit Hassan; Melissa F Campo; Earl F Albone; Peter L Choyke; Ira Pastan; Chang H Paik
Journal:  Nucl Med Biol       Date:  2011-07-07       Impact factor: 2.408

4.  Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium.

Authors:  D Buchsbaum; B Randall; D Hanna; R Chandler; M Loken; E Johnson
Journal:  Eur J Nucl Med       Date:  1985

5.  A fluorescence quenching method for estimating chelating groups in chelate-conjugated macromolecules.

Authors:  W Ma; K J Hwang; V H Lee
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

6.  Use of the gamma-ray perturbed angular correlation (PAC) technique for monitoring liposomal phospholipid bilayer integrity.

Authors:  W Ma; K J Hwang; V H Lee
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

7.  Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen.

Authors:  B Collet; P Pellen; A Martin; A Moisan; D Bourel; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 8.  New magnetic resonance imaging techniques for the detection of breast cancer.

Authors:  K Orang-Khadivi; B L Pierce; C M Ollom; L J Floyd; R L Siegle; R F Williams
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.